Cibc Private Wealth Group, LLC Neuronetics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $56.1 Billion
- Q3 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 20 shares of STIM stock, worth $39. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$39
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
110Shares Held
21.7MCall Options Held
1.58MPut Options Held
213K-
Vanguard Group Inc Valley Forge, PA2.83MShares$5.58 Million0.0% of portfolio
-
Ubs Group Ag2.16MShares$4.26 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.82MShares$3.59 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.42 Million1.44% of portfolio
-
Wexford Capital LP Greenwich, CT1.18MShares$2.32 Million0.49% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $53.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...